Expanding Access to Noninvasive Prenatal Testing in Abu Dhabi

This white paper examines the barriers to adopting noninvasive prenatal testing (NIPT) in Abu Dhabi and outlines strategies to ensure broader patient access. It describes the complex process of market access for new technologies, emphasizing the need for communication among governments, clinicians, and insurance companies. The paper highlights the collaboration between Illumina and IQVIA, detailing global adoption trends and the benefits of NIPT for prenatal screening. It notes the increasing recognition of genetic testing's value in the UAE, with recent recommendations for NIPT usage by the Dubai Health Authority. Despite sporadic use, the paper identifies barriers such as insurance coverage, limited clinician awareness, and cultural factors that hinder access. It suggests steps to improve access, including clinician education, insurance reforms, and the establishment of specialized prenatal care clinics. The ultimate goal is to expand NIPT coverage across the UAE and potentially influence the broader Asia, Middle East, and Africa regions.